Gastritis clinical trials
The registry lists 135 studies for Gastritis across more than 10 countries. 23 are recruiting or about to start. 101 of them are mainly about Gastritis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-04. Counting its 2 narrower conditions too, such as Gastritis, Atrophic: 231 studies, 63 open.
Get an email when these change. Save the Gastritis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Xijing Hospital of Digestive Diseases (9) · Daewoong Pharmaceutical Co. LTD. (5) · Dong-A ST Co., Ltd. (4) · Addpharma Inc. (4) · Changhai Hospital (3) · Daewon Pharmaceutical Co., Ltd. (3) · Chong Kun Dang Pharmaceutical (3) · Hamamatsu University (3)
What is being tested here
Drugs under test in Gastritis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Levofloxacin | 1 | 0 | 2 |
| Holy basil leaf extract | 1 | 1 | 1 |
| Amoxicillin | 0 | 2 | 6 |
| Clarithromycin | 0 | 2 | 4 |
| Esomeprazole | 0 | 0 | 3 |
| Berberine | 0 | 0 | 3 |
| Metronidazole | 0 | 1 | 2 |
| Rabeprazole | 0 | 1 | 2 |
| Vonoprazan | 0 | 1 | 1 |
| Clostridium butyricum | 0 | 0 | 1 |
Drug classes tested here Proton pump inhibitors (PPIs) 6
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
Who these studies take
Of the 11 Gastritis studies recruiting now, 6 (55%) set no upper age limit and 5 (45%) stop at 75 or younger. 1 (9%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (18%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 1 (9%) | 1 (9%) |
| 18 | 8 (73%) | 8 (73%) |
| 30 | 10 (91%) | 10 (91%) |
| 40 | 10 (91%) | 10 (91%) |
| 50 | 11 (100%) | 11 (100%) |
| 65 | 10 (91%) | 10 (91%) |
| 75 | 8 (73%) | 8 (73%) |
| 85 | 6 (55%) | 6 (55%) |
Across all 135 studies, recruiting or not: 50% stop at 75 or younger and 21% at 65; 16% take children; 0% are for women only and 3% for men only; 21% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Gastritis studies take
Of 14 phase 4 interventional studies under Gastritis, half reached primary completion within 12 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Phase 3 | 6 mo4–17 · 11 studies | — | — |
| Phase 4 | 12 mo7–14 · 14 studies | — | — |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
Studies
Recruiting first, then most recently updated. Showing 50 of 135. Browse all 135 → or search them.
- NLR and PLR in H. Pylori-Associated GastritisNot yet recruitingNCT07805005
- The Prevalence and the Pathophysiological Role of Non-Helicobacter Pylori Helicobacter Spp. in Well-defined Gastric Diseases and (Pre-) MalignanciesRecruitingNCT077701261 country
- A Study of Compare the Pharmacokinetic, Pharmacodynamic and Safety/Tolerability Characteristics Following Multiple Oral Administration of AD-234, AD-2341, and AD-2342 in Healthy AdultsNot yet recruitingNCT07717775Phase 11 country
- Safety and Efficacy Study of Betaine Hydrochloride in Treating Hypergastrinemia in Patients With Autoimmune GastritisRecruitingNCT06272500Not applicable1 country
- Phase 4 Study of Sto M Tab. in Acute or Chronic GastritisNot yet recruitingNCT07631065Phase 4
- Vonoprazan High-Dose Dual VS Levofloxacin ConcomitantNot yet recruitingNCT07624422Phase 41 country
- Study of Gastric Motility in Eosinophilic GastritisRecruitingNCT052294321 country
- Holy Basil in The Treatment of DyspepsiaRecruitingNCT07175272Phase 2/31 country
- A Clinical Trial to Assess the Pharmacokinetics and Safety of AD-229 Compared to AD-2291 in Healthy AdultsNot yet recruitingNCT07385248Phase 1
- miRNA in Pediatric GastritisNot yet recruitingNCT07300787Not applicable1 country
- Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue TreatmentRecruitingNCT07139366Phase 41 country
- Efficacy of Carminal in Helicobacter Pylori GastritisRecruitingNCT07179237Phase 21 country
- Clinical Evaluation of a 14day Modified Bismuth Quadruple Therapy for the Eradication of Helicobacter Pylori in a High Clarithromycin and Metronidazole Resistance Area Regarding Patients With Peptic Ulcer and Non Ulcer DyspepsiaNot yet recruitingNCT07146594Phase 4
- Relationship Between Diet and GastritisNot yet recruitingNCT071298241 country
- Efficacy Comparison of Vonoprazan Combined With Different Antibiotics in Dual Therapy for Helicobacter Pylori Eradication: A Prospective, Randomized Controlled Clinical TrialRecruitingNCT07068607Phase 41 country
- Comparison of the Sensitivity of pCLE and Pathological Biopsy Before ESDNot yet recruitingNCT070887441 country
- Efficacy and Safety of FEXUCLUE Tab. In Patients With Acute or Chronic GastritisRecruitingNCT069484871 country
- A Cohort Study of Mobile Capsule Gastroscopy for Gastric Pathologies ScreeningRecruitingNCT070329611 country
- Assessing the Prevalence and Epidemiological Characteristics of Small Intestinal Bacterial Overgrowth (SIBO) in Patients With Autoimmune Gastritis(AIG) Through Hydrogen and Methane Breath Testing(HMBT).RecruitingNCT069467061 country
- Helicobacter Pylori Gastritis and Its Relation to Metabolic Syndrome ComponentsNot yet recruitingNCT06935955
- The Application of the PDCA Management Model in Improving the Diagnostic Accuracy of AIGNot yet recruitingNCT065572521 country
- Post-Marketing Surveillance of Safety and Effectiveness of Mucosta®SR Tab.RecruitingNCT050480691 country
- Correlation Between H.Pylori Colonization and GastritisNot yet recruitingNCT06015763Not applicable
- To Develop Methods for the Rehabilitation of Chronic Gastroduodenal Pathology in Children.Active, not recruitingNCT04702542Not applicable1 country
- Vedolizumab for the Treatment of Collagenous GastritisActive, not recruitingNCT06317220Phase 21 country
- Capsule Gastric Endoscopy for Gastric Disease Screening in Simulated Home ScenariosCompletedNCT06848400Not applicable3 countries
- Evaluation of Microbial Status in Gastritis Patients in Different Periodontal ConditionsCompletedNCT073785401 country
- Genomic Resources for Enhancing Available Therapies (GREAT1.0) StudySuspendedNCT043069391 country
- Establishment and Effectiveness Evaluation of a Training System for Confocal Laser EndomicroscopyCompletedNCT069818191 country
- Bioequivalence Study to Compare Vonoprazan 20 mg Film Coated Tablets Versus Voquezna® 20 mg (Vonoprazan) TabletsCompletedNCT07278349Phase 11 country
- A Study to Evaluate the Safety and Efficacy of DA9601 for Acute and Chronic Gastritis and to Determine the Optimal Clinical Dosage and AdministrationCompletedNCT07139886Phase 21 country
- Clinical Trial to Evaluate the Efficacy and Safety of DA-5219 in Patients With Acute or Chronic GastritisCompletedNCT06151210Phase 31 country
- Study on The Efficacy and Safety of Vonoprazan-containing Berberine Triple Therapy in Helicobacter Pylori First-Line EradicationCompletedNCT06514274Phase 41 country
- Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal MicroecologyCompletedNCT05742568Phase 41 country
- Helicobacter Rescue Therapy With Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple TherapyCompletedNCT06168084Phase 41 country
- 7 Days vs. 14 Days of Vonoprazan-based Triple Therapy for H. Pylori EradicationCompletedNCT06576882Phase 31 country
- To Evaluate Improvement Effect of Subjective Symptoms of Mucotra SR Tablet in Patients With GastritisCompletedNCT066685061 country
- Clinical Trial to Compare Rebamipide/Nizatidine Combination Therapy With Nizatidine Monotherapy in Patients With GastritisCompletedNCT05072938Phase 41 country
- Evaluation of Antral Biopsies Obtained in Normal EsophagogastroduodenoscopyCompletedNCT06269380Not applicable1 country
- Systems Biology of Gastrointestinal and Related DiseasesTerminatedNCT055794441 country
- MAGNET (Magnetically Controlled Capsule for Assessment of Gastric Mucosa in Symptomatic Patients)CompletedNCT04724291Not applicable1 country
- Telephone Counseling in the Education of the Patient With GastritisCompletedNCT04669275Not applicable1 country
- Clinical Characteristics, Lifestyle and Multi-omics Analysis in Autoimmune GastritisStatus unknownNCT058206071 country
- Efficacy and Safety of Houtou Jianweiling Tablet in the Treatment of Chronic Non-Atrophic GastritisCompletedNCT04672018Phase 21 country
- Effect of ALBIS on Gastroduodenal Mucosal Injury in Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coronary InterventionCompletedNCT02175186Phase 41 country
- Study on The Efficacy and Safety of Berberine-containing Triple Therapy in Helicobacter Pylori First-Line EradicationCompletedNCT05014334Phase 41 country
- Helicobacter Rescue Therapy With High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple TherapyCompletedNCT04678492Phase 41 country
- Sedation Level on Machine Learning With Electroencephalogram in Painless Gastroenteroscopy PatientsStatus unknownNCT055453971 country
- HFNO Reduces Hypoxia During Sedated Gastroscopy or Colonoscopy in High Risk PatientsStatus unknownNCT05510388Not applicable1 country
- Study to Evaluate the Efficacy and Safety of HIP2101 in Patients With Acute or Chronic GastritisCompletedNCT05024721Phase 31 country